Editorial Note: AbbVie's current legal action against the European Medicines Agency's policy on access to clinical trial data led to the idea of an AbbVie - getting people on any drugs at all, especially new drugs and in particular biologicals, to do two things: 1. Report any of the effects they are having on RxISK.org 2. Sign the petition below AbbVie applied to block … [Read more...] about The Humira Trials: Judith’s Story
Stacy London: What Not To Take
Three weeks ago Johanna Ryan and Kim Witczak wrote a letter to Stacy London about Humira and AbbVie. They were hoping for a response but there has been none so far. There’s something about Stacy Stacy London of What Not to Wear fame has a lot going for her. She is a successful business woman, style guru and role model for women around the world. AbbVie must be delighted to … [Read more...] about Stacy London: What Not To Take
Welcome to the Humiraverse
Editorial Note: This post in the AbbVie series is by Johanna Ryan from the RxISK Community Advisory Board I recently read a legal complaint filed against AbbVie by a New York woman named Cynthia Di Bartolo. She’s a successful corporate lawyer who had undergone various treatments for psoriasis over the years, including medications and ultraviolet light therapy. In November 2008 … [Read more...] about Welcome to the Humiraverse
Democracy in Adversity
This post stands in stark contrast to EU-nuch in the Humira-m. There could not be a greater contrast between the way companies now sell drugs globally and the way they attempt to restrict the reporting of adverse events. The infographic below from Kayla brings out the point. Sales are now global. AbbVie's plans for Humira and the plans other companies have for their … [Read more...] about Democracy in Adversity
EU-nuch in the Humira-m
No such thing as being 'European' There is no such thing as being European when you take a drug like Humira or Depakote and something goes wrong. When something goes wrong on their drug, companies go to extraordinary lengths to make it almost impossible for doctors or patients to report adverse events. It’s part of a larger mission to transform what were poisons to be used … [Read more...] about EU-nuch in the Humira-m
Humira in Ulcerative Colitis
Editorial Note: I have to thank Ken Spriggs for pointing out the Humira in Ulcerative Colitis Review site. For anyone interested in AbbVie-ing and in Humira this site offers some sobering reading. Humira in ulcerative colitis reviews With the recent approval of Humira (Adalimumab) by the FDA, there is a growing need for ulcerative colitis patient reviews of their experiences … [Read more...] about Humira in Ulcerative Colitis
Brands Don’t Have Side Effects: crohnsforum.com
Editorial Note: This post is by Ken Spriggs, who wrote the second ever RxISK story - on Azathiopine. This should be revisited in the light of the AbbVie Campaign. The current post is taken from his ongoing blog on Crohn's Disease - a condition that is high on the target list for the makers of biologicals including AbbVie and Humira. Drug side effect ratios explained This is … [Read more...] about Brands Don’t Have Side Effects: crohnsforum.com
AbbVie: Humira Timeline
Editorial Note: An article in Forbes this week suggested Humira is set to become the biggest selling drug of all time. The timeline below, found by Harriet Rosenberg on the JusticeSeekers' website, covers the timeline of its elevation to the blockbuster Hall of Fame. This post and several to come are part of a sequence outlining how we can all help make Humira a better … [Read more...] about AbbVie: Humira Timeline
Let’s Do The AbbVie Again
The idea of a Boycott is an Irish invention. During the Land Wars in 1880, when Colonel Boycott on behalf of Lord Erne unscrupulously evicted tenants who didn't pay rent following a bad harvest, no one moved in to rent the vacant farms. Everyone refused to talk to Boycott. He was ostracised completely. The tactic worked so well that within months the Times of London was talking … [Read more...] about Let’s Do The AbbVie Again
Reading the RIAT Act
Editorial Note: This is a press release for a potentially important development in medicine. You can access your copy of the RIAT Act here and an assessment of its likely significance here. Restoring invisible and abandoned trials (RIAT) “to correct the scientific record” Sponsors and researchers will be given one year to act before independent scientists begin publishing the … [Read more...] about Reading the RIAT Act